在多囊卵巢妇女中对NEUREGULIN-1的METFORMIN影响
Georgian medical news
|June 24, 2023
概括
多囊性卵巢综合征 (PCOS) 患者表现出较高的神经调节素1 (NRG1) 水平. 在患有PCOS的女性中,甲福明治疗显著降低了NRG1,胰岛素抵抗和BMI.
科学领域:
- 内分泌学 在内分泌学.
- 生殖健康 生殖健康
背景情况:
- 多囊卵巢综合征 (PCOS) 是一种普遍存在的内分泌疾病,影响生殖年龄的女性.
- 神经调节素1 (NRG1) 在炎症和排卵调节中发挥作用.
研究的目的:
- 在患有PCOS的女性中评估Neuregulin 1 (NRG1) 水平.
- 评估甲福明对PCOS患者血清NRG1水平的影响.
主要方法:
- 一项涉及60名患有PCOS的女性和30名健康对照者的横截面研究.
- 根据鹿特丹标准诊断PCOS.
- 测量BMI,胰岛素耐药性和禁食血清NRG1在甲福林治疗 (850毫克/天) 3个月前后.
主要成果:
- 与对照组相比,患有PCOS的女性表现出更高的空腹血糖,胰岛素,胰岛素抵抗和NRG1水平.
- 甲胺治疗导致BMI,血糖,胰岛素和胰岛素耐药性显著降低.
- 在3个月的甲福明治疗后,血清NRG1水平显著下降.
结论:
- 较高的NRG1水平与PCOS有关.
- 甲胺在改善代谢参数和降低PCOS妇女的NRG1水平方面是有效的.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240
Oogenesis
63.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.9K
Dipeptidyl Peptidase 4 Inhibitors
214
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
214
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Oral Hypoglycemic Agents: Glinides
189
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
189


